Position in HALO
as of Mar 31, 2026
· filed May 14, 2026
Position Value
$11,270,050
-$3,507,616 QoQ
Shares Held
174,378
-20.6% QoQ
Ownership
0.147%
of shares outstanding
% of Portfolio
0.11%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2023
9 quarters on record
Voting authority
Sole 0.ToString("F0")%
Shared 100.ToString("F0")%
None 0.ToString("F0")%
Common Shares in HALO Over Time
Shares Held
Position Value (USD)
Derivatives in HALO
reported options exposure · as of Mar 31, 2024CallValue
$504,432
CallShares
12,400
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Mar 31, 2026CAPITAL FUND MANAGEMENT S.A. holds $292,594,996 across 34 Biotechnology names. HALO ranks #6 (3.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
122,934 | $54,894,948 | |
| 2 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
140,109 | $46,357,864 | |
| 3 | INCY |
Incyte Corp
|
312,021 | $29,367,416 | |
| 4 | MRNA |
Moderna, Inc.
|
569,930 | $28,952,444 | |
| 5 | EXEL |
Exelixis, Inc.
|
479,693 | $20,574,032 | |
| 6 | HALO |
Halozyme Therapeutics, Inc.
This page
|
174,378 | $11,270,050 | |
| 7 | IONS |
Ionis Pharmaceuticals Inc
|
142,201 | $10,677,873 | |
| 8 | BMRN |
Biomarin Pharmaceutical Inc
|
181,065 | $10,228,361 |
All Filings in HALO
Export CSV
14 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $11,270,050 | 174,378 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $14,777,666 | 219,579 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $15,602,424 | 212,741 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $5,613,530 | 107,911 | Shares | Sole | 2025-08-13 | |
| 2024-12-31 | $1,118,084 | 23,386 | Shares | Sole | 2025-02-13 | |
| 2024-03-31 | $2,422,575 | 59,552 | Shares | Sole | 2024-05-15 | |
| 2024-03-31 | $504,432 | 12,400 | Call | Sole | 2024-05-15 | |
| 2023-12-31 | $1,515,396 | 41,001 | Shares | Sole | 2024-02-14 | |
| 2023-12-31 | $543,312 | 14,700 | Put | Sole | 2024-02-14 | |
| 2023-12-31 | $687,456 | 18,600 | Call | Sole | 2024-02-14 | |
| 2023-09-30 | $1,608,220 | 42,100 | Call | Sole | 2023-11-14 | |
| 2023-09-30 | $580,640 | 15,200 | Put | Sole | 2023-11-14 | |
| 2023-09-30 | $542,134 | 14,192 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $1,893,675 | 52,500 | Call | Sole | 2023-08-14 | |
| No filing history on record for this holder in this stock. | ||||||